BlackBerry, JVCKENWOOD and SK Telecom Join Sisvel POS Patent Pool as Licensors
LUXEMBOURG, April 17, 2026–(BUSINESS WIRE)–The new Sisvel Point of Sale (POS) patent pool, announced on 1 April, has…
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…